Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Carcinoma, Transitional Cell
Description
A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. MeSH
Hierarchy View
Approved Indicated Drugs (3)
Phase 3 Indicated Drugs (43)
Phase 2 Indicated Drugs (119)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (62)
Associació per a la Recerca Oncologica, Spain
Association of Urogenital Oncology (AUO)
Azienda Ospedaliera San Camillo Forlanini
Cancer and Leukemia Group B (CALGB)
European Organisation for Research and Treatment of Cancer
German Association of Urologic Oncology
Groupe D'Etude des Tumeurs Uro-Genitales
National Cancer Institute (NCI)
National Health and Medical Research Council, Australia
Princess Al-Johara Al-Ibrahim Cancer Research Center
Shanghai Junshi Bioscience Co.,Ltd.
Organization Involved with Phase 2 Indications (185)
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)
Beijing Huanxing Cancer Hospital
Cancer Immunotherapy Trials Network
Case Western Reserve University
Centre Georges Francois Leclerc
Centre Hospitalier Universitaire de Nīmes
Chinese Academy of Medical Sciences
Choithram Hospital and Research Centre
Christian Medical College, Vellore, India
City of Hope National Medical Center
GZA Ziekenhuizen Campus Sint-Augustinus
Herbert Irving Comprehensive Cancer Center
Hoosier Cancer Research Network
Hôpital Européen Georges-Pompidou
Hospital Universitario Fundación Alcorcón
Icahn School of Medicine at Mount Sinai
Infinity Pharmaceuticals, Inc.
Institute of Post Graduate Medical Education & Research
Latin American Cooperative Oncology Group
Memorial Sloan-Kettering Cancer Center
Oregon Health and Science University
People's Liberation Army of China
Postgraduate Institute of Medical Education and Research
Radiation Therapy Oncology Group
Sarcoma Oncology Research Center, LLC
Seth Gordhandas Sunderdas Medical College
Shandong New Time Pharmaceutical Co., LTD
Shenzhen Geno-Immune Medical Institute
State University of New York, Buffalo
Technical University of Munich
The European Uro-Oncology Group
Universidad Complutense de Madrid
Université catholique de Louvain
University of California, Davis
University of California, Irvine
University of California, Los Angeles
University of California, San Francisco
University of Colorado, Denver
University of Nice Sophia Antipolis
University of North Carolina at Chapel Hill
University of Southern California
University of Texas at Houston
Organization Involved with Other Experimental Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.